Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY-NH study of esaxerenone in uncontrolled nocturnal hypertension
jRCTs031200364Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esaxerenone in nocturnal hypertension (NH), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change from baseline in nocturnal blood pressure measured by brachial sphygmomanometer. Started Apr 2021; status: completed.
02
Drugs
esaxerenone
03
Conditions
nocturnal hypertension (NH)
Beyond the preview
Go deeper on jRCTs031200364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200364.